Lina Benson's research while affiliated with Stockholm Resilience Centre and other places

What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (3)

Cite
Download full-text
Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry
Conference Paper
  • Dec 2015
Purpose The rates of early mortality (EM) are high in patients receiving intensive chemotherapy for acute myeloid leukemia (AML). Decreasing EM-rates over time have recently been reported. The reason for the improvement is however elusive and generally attributed to better supportive antibiotic and antifungal treatment. We wanted to investigate th...
Cite
Request full-text
Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry
Article
  • Dec 2015
Purpose The rates of early mortality (EM) are high in patients receiving intensive chemotherapy for acute myeloid leukemia (AML). Decreasing EM-rates over time have recently been reported. The reason for the improvement is however elusive and generally attributed to better supportive antibiotic and antifungal treatment. We wanted to investigate thi...
Cite
Request full-text

Citations

... In conclusion, this study demonstrates a steady increase in AML survival in all but the 80-89-year-old pateints. According to SE and DK experience, survival gains were accomplished through more intensive therapy, novel agents (yet many of them were introduced only recently), extended use of HSCT, improved supportive care and overall population health [6,8,14]. The preferential survival improvements in young patients lead to widening of the age-related survival gap. ...
Reference: Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century
View full-text